Addus HomeCare Co. (NASDAQ:ADUS) Stock Holdings Increased by Ellsworth Advisors LLC

Ellsworth Advisors LLC lifted its holdings in Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 6.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,692 shares of the company’s stock after purchasing an additional 348 shares during the quarter. Ellsworth Advisors LLC’s holdings in Addus HomeCare were worth $713,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. American Century Companies Inc. grew its position in Addus HomeCare by 90.6% in the 2nd quarter. American Century Companies Inc. now owns 18,393 shares of the company’s stock valued at $2,136,000 after buying an additional 8,743 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock valued at $82,930,000 after acquiring an additional 5,421 shares during the period. Amalgamated Bank increased its stake in shares of Addus HomeCare by 8.4% during the second quarter. Amalgamated Bank now owns 5,330 shares of the company’s stock valued at $619,000 after acquiring an additional 412 shares during the period. Intech Investment Management LLC bought a new stake in Addus HomeCare during the second quarter worth approximately $245,000. Finally, Sei Investments Co. lifted its position in Addus HomeCare by 22.2% in the second quarter. Sei Investments Co. now owns 13,770 shares of the company’s stock worth $1,599,000 after purchasing an additional 2,499 shares during the period. 95.35% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the transaction, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This represents a 8.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. This represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 39,750 shares of company stock valued at $4,930,750. 4.60% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ADUS. KeyCorp initiated coverage on Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective on the stock. JMP Securities assumed coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price target for the company. StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Thursday. Stephens raised their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Finally, Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. One analyst has rated the stock with a sell rating, one has given a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $133.67.

Read Our Latest Stock Report on ADUS

Addus HomeCare Stock Performance

ADUS stock opened at $133.87 on Monday. The firm has a 50 day simple moving average of $125.28 and a 200 day simple moving average of $126.59. Addus HomeCare Co. has a 52 week low of $85.94 and a 52 week high of $136.12. The stock has a market cap of $2.43 billion, a P/E ratio of 30.63, a P/E/G ratio of 1.63 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last issued its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. During the same quarter in the previous year, the company posted $1.03 earnings per share. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. Sell-side analysts predict that Addus HomeCare Co. will post 4.58 EPS for the current year.

About Addus HomeCare

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Articles

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.